Synergistic activity of phenazines isolated from Pseudomonas aeruginosa in combination with azoles against Candida species

Medical Mycology

Volumn 52, Issue 5, 2014, Pages 480-488

  Nishanth Kumar, S ^a   Nisha, G V ^a   Sudaresan, A ^a   Venugopal, V V ^a   Sree Kumar, M M ^a   Lankalapalli, Ravi S ^a   Dileep Kumar, B S ^a  

^a REGIONAL RESEARCH LABORATORY CSIR   (India)

Author keywords

azoles; Candida species; phenazines; synergistic

Indexed keywords

ANTIFUNGAL AGENT; CISPLATIN; CLOTRIMAZOLE; CYTOTOXIC AGENT; FLUCONAZOLE; ITRACONAZOLE; PHENAZINE 1 CARBOXAMIDE; PHENAZINE 1 OL; PHENAZINE DERIVATIVE; PHENAZINE1 CARBOXYLIC ACID; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; PHENAZINE 1 CARBOXYLIC ACID;

ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CANDIDA TROPICALIS; CHRONOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENTIATION; DRUG PURIFICATION; FIBROBLAST CULTURE; FUNGUS GROWTH; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MTT ASSAY; NONHUMAN; PSEUDOMONAS AERUGINOSA; ANTIFUNGAL RESISTANCE; BACTERIUM ISOLATION; CANDIDA; CYTOTOXICITY; PREPUCE; SKIN FIBROBLAST; CELL LINE; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY;

CANDIDA; PSEUDOMONAS AERUGINOSA;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA; CELL LINE; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PHENAZINES; PSEUDOMONAS AERUGINOSA;

EID: 84903217762     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myu012     Document Type: Article

References (35)

1. Garcia-Gomes AS, Curvelo JAR, Soares RMA, Ferreira-Pereira A. Curcumin acts synergistically with fluconazole to sensitize a clinical isolate of Candida albicans showing a MDR phenotype. Medical Mycol 2012; 50: 26-32.
2. Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006; 2: e129.
3. Koehler AP, Chu KC, Houang ET, Cheng AF. Simple, reliable and cost effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 1999; 37: 422-426.
4. Chakrabarti A, Chatterjee SS, Rao KL et al. Recent experience with fungaemia: change in species distribution and azole resistance. Scand J Infect Dis 2009; 41: 275-284.
5. Calderone RA. Introduction and historical perspectives. In: Calderone RA, ed. Candida and Candidiasis Washington, DC: American Society for Microbiology, 2002: 3-13.
6. Brown GD, Denning DW, Gow NA et al. Hidden killers: human fungal infections. Sci Transl Med 2012; 4: 165rv113.
7. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640-3645.
8. Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol 2003; 11: 272-279.
9. Khodavandi A, Alizadeh F, Aala F, Sekawi Z, Chong PP. In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species. Mycopathol 2010; 169: 287-295.
10. Chen YL, Lehman VN, Averette AF, Perfect JR, Heitman J. Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. PLoS One 2013; 8: e57672.
11. Laursen JB, Nielsen J. Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem Rev 2004; 104: 1663-1685.
12. Mavrodi DV, Blankenfeldt W, Thomashow LS. Phenazine compounds in fluorescent Pseudomonas species biosynthesis and regulation. Annu Rev Phytopathol 2006; 44: 417-445.
13. Liu HM, He YJ, Jiang HX et al. Characterization of a phenazine-producing strain Pseudomonas chlororaphis GP72 with broad-spectrum antifungal activity from green pepper rhizosphere. Curr Microbiol 2007; 54: 302-306.
14. Veselova MA, Klein S, Bass IA et al. Quorum sensing systems of regulation, synthesis of phenazine antibiotics, and antifungal activity in rhizospheric bacterium Pseudomonas chlororaphis. Russian J Genetics 2008; 44: 1400-1408.
15. Shanmugaiah V, Mathivanan N, Varghese B. Purification, crystal structure and antimicrobial activity of phenazine-1-carboxamide produced by a growth-promoting biocontrol bacterium, Pseu-domonas aeruginosa MML2212. J Appl Microbiol 2010; 108: 703-711.
16. Morohoshi T, Wang WZ, Suto T et al. Phenazine antibiotic production and antifungal activity are regulated by multiple quorum-sensing systems in Pseudomonas chlororaphis subsp. aurantiaca StFRB508. J Biosci Bioeng 2013; 116: 580-584.
17. Hindler JA. Special antimicrobial susceptibility tests. In: Mahon CR, Manusalis G, eds. Text Book of the Diagnostic Microbiology, 2nd edn. Philadelphia: WB Saunders, 2000: 97-104.
18. Chen YL, Lehman VN, Averette AF, Perfect JR, Heit-man J. Posaconazole exhibits in vitro and in vivo syn-ergistic antifungal activity with caspofungin or fk506 against Candida albicans. PLoS One 2013; 8: e57672. doi:10.1371/journal.pone.0057672.
19. George M, Eliopoulos GM, Robert C, Moellering JR. Antimicrobial Combinations. Antibiotics in Laboratory Medicine. Baltimore: Williams and Wilkins, 1996: 330-396.
20. Anto RJ, Venkataraman M, Karunagaran D. Inhibition of NF-KB sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance. J Biol Chem 2003; 28: 25490-25498.
21. Arif T, Bhosale JD, Kumar N et al. Natural products-antifungal agents derived from plants. J Asian Nat Prod Res 2009; 11: 621-638.
22. Cowan MM. Plant products as antimicrobial agents. Clin Mi-crobiol Rev 1999; 12: 564-582.
23. Chung PY, Parasakthi N, Chung LY. Synergistic antimicrobial activity between pentacyclic triterpenoids and antibiotics against Staphylococcus aureus strains. Ann Clin Microbiol Antimicrobial 2011; 10: 1-6.
24. Lee Y, Jang K, Cha J. Synergistic antibacterial effect between silibinin and antibiotics in oral bacteria. J Biomed Biotech 2012; ID 618081: 1-7.
25. Kumar SN, Nambisan B, Mohandas C, Sundaresan A. In vitro synergistic activity of diketopiperazines alone and in combination with amphotericin B and clotrimazole against Candida albi-cans. Folia Microbiol 2013 (DOI: 10.1007/s12223-013-0234-x).
26. Sweeney MT, Zurenko GE. In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, En-terococci, Pneumococci, and selected gram-negative organisms. Antimicrob Agents Chemother 2003; 47: 1902-1906.
27. Hodgkinson JT, Galloway WRJD, Saraf S et al. Microwave and flow syntheses of Pseudomonas quinolone signal (PQS) and analogues. Org Biomol Chem 2011; 9: 57-61.
28. Kumar RS, Ayyadurai N, Pandiaraja P, Reddy AV, Venkateswarlu Y. Characterization of antifungal metabolite produced by a new strain Pseudomonas aeruginosa PUPa3 that exhibits broad-spectrum antifungal activity and biofertilizing traits. J Appl Microbiol 2005; 98: 145-154.
29. Morales DK, Grahl N, Okegbe C et al. Control of Candida albicans metabolism and biofilm formation by Pseu-domonas aeruginosa phenazines. mBio 2013; 4: e00526-12. doi:10.1128/mBio.00526-12.
30. Morales DK, Jacobs NJ, Rajamani S et al. Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms. Mol Microbiol 2010; 78: 1379-1392.
31. Girmenia C, Venditti M, Martino P. Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections. Diagn Microbiol Infect Dis 2003; 46: 227-231.
32. Cruz MC, Goldstein AL, Blankenship JR et al. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 2002; 21: 546-559.
33. Quan H, Cao YY, Xu Z et al. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother 2006; 50: 1096-1099.
34. Cowen LE, Lindquist S. Hsp90 potentiates the rapid evolution of new traits: Drug resistance in diverse fungi. Science 2005; 309: 2185-2189.
35. Heitman J. A fungal achilles' heel. Science 2005; 309: 2175-2176.